BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1716905)

  • 1. Biogenic amines and metabolites in spinal cord of patients with Parkinson's disease and amyotrophic lateral sclerosis.
    Sofic E; Riederer P; Gsell W; Gavranovic M; Schmidtke A; Jellinger K
    J Neural Transm Park Dis Dement Sect; 1991; 3(2):133-42. PubMed ID: 1716905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyotrophic lateral sclerosis: changes of noradrenergic and serotonergic transmitter systems in the spinal cord.
    Bertel O; Malessa S; Sluga E; Hornykiewicz O
    Brain Res; 1991 Dec; 566(1-2):54-60. PubMed ID: 1726065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degeneration of noradrenergic and serotonergic but not dopaminergic neurones in the lumbar spinal cord of parkinsonian patients.
    Scatton B; Dennis T; L'Heureux R; Monfort JC; Duyckaerts C; Javoy-Agid F
    Brain Res; 1986 Aug; 380(1):181-5. PubMed ID: 2428421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Histopathological and immunohistochemical study of spinal cord tissues in neurodegenerative diseases].
    Zhu M; Wang L; Liu J; Gui Q; Guo Y; Hu Y; Zhang H
    Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):587-93. PubMed ID: 26705184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new microdissection technique for regional biochemical analysis of the rat spinal cord: serotonin, norepinephrine, dopamine and uric acid.
    Basbaum AI; Godefroy F; Weil-Fugazza J
    Brain Res; 1987 Sep; 419(1-2):229-38. PubMed ID: 2445422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticoliberin, somatocrinin and amine contents in normal and parkinsonian human hypothalamus.
    Conte-Devolx B; Grino M; Nieoullon A; Javoy-Agid F; Castanas E; Guillaume V; Tonon MC; Vaudry H; Oliver C
    Neurosci Lett; 1985 May; 56(2):217-22. PubMed ID: 2409485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease.
    Palmer AM; Wilcock GK; Esiri MM; Francis PT; Bowen DM
    Brain Res; 1987 Jan; 401(2):231-8. PubMed ID: 2434191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolism of L-DOPA and L-threo-3,4-dihydroxyphenylserine and their effects on monoamines in the human brain: analysis of the intraventricular fluid from parkinsonian patients.
    Maruyama W; Naoi M; Narabayashi H
    J Neurol Sci; 1996 Jul; 139(1):141-8. PubMed ID: 8836986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Narcolepsy: biogenic amine deficits in an animal model.
    Mefford IN; Baker TL; Boehme R; Foutz AS; Ciaranello RD; Barchas JD; Dement WC
    Science; 1983 May; 220(4597):629-32. PubMed ID: 6188216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase of the serotonin metabolite, 5-hydroxyindoleacetic acid, in cerebro-spinal fluid and spinal cord of bovines affected with the paraplegic syndrome.
    Lima L; Urbina M; Drujan B
    Acta Cient Venez; 1995; 46(3):161-5. PubMed ID: 9334442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the noradrenaline neurotoxin DSP 4 on monoamine neurons and their transmitter turnover in rat CNS.
    Hallman H; Sundström E; Jonsson G
    J Neural Transm; 1984; 60(2):89-102. PubMed ID: 6208323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered serotonin and dopamine metabolism in the CNS of serotonin 5-HT(1A) or 5-HT(1B) receptor knockout mice.
    Ase AR; Reader TA; Hen R; Riad M; Descarries L
    J Neurochem; 2000 Dec; 75(6):2415-26. PubMed ID: 11080193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional distribution of monoamines and their metabolites in the human brain.
    Mackay AV; Yates CM; Wright A; Hamilton P; Davies P
    J Neurochem; 1978 Apr; 30(4):841-8. PubMed ID: 650225
    [No Abstract]   [Full Text] [Related]  

  • 14. The synthesis and metabolism of catecholamines in the spinal cord of the rat after acute and chronic transections.
    Commissiong JW
    Brain Res; 1985 Nov; 347(1):104-11. PubMed ID: 2864984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease.
    Scatton B; Javoy-Agid F; Rouquier L; Dubois B; Agid Y
    Brain Res; 1983 Sep; 275(2):321-8. PubMed ID: 6626985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional brain contents of serotonin, dopamine and their metabolites in the selectively bred high- and low-alcohol drinking lines of rats.
    Gongwer MA; Murphy JM; McBride WJ; Lumeng L; Li TK
    Alcohol; 1989; 6(4):317-20. PubMed ID: 2475142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of neonatal 5,7-dihydroxytryptamine treatment on the development of serotonin neurons and their transmitter metabolism.
    Ponzio F; Jonsson G
    Dev Neurosci; 1978; 1(2):80-9. PubMed ID: 755684
    [No Abstract]   [Full Text] [Related]  

  • 18. The spinal monoaminergic systems relating to ejaculation ejaculation and monoamines after spinal cord transection.
    Miyamoto A; Yonezawa A; Tadano T; Kisara K; Kimura Y
    Andrologia; 1986; 18(1):56-62. PubMed ID: 2420237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of change in indoleamine metabolism in spinal cord of patients with amyotrophic lateral sclerosis.
    Ohsugi K; Adachi K; Mukoyama M; Ando K
    Neurosci Lett; 1987 Aug; 79(3):351-4. PubMed ID: 2443876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin and norepinephrine in the spinal cord of man.
    Lacković Z; Jakupcević M; Bunarević A; Damjanov I; Relja M; Kostović I
    Brain Res; 1988 Mar; 443(1-2):199-203. PubMed ID: 2451990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.